FDA Adverse Event Injury Summary report: N

SUR-FIT NATURA 2 PC DURAHESIVE CONVEX MOLDABLE

MDR report key: 3936077 · Received June 23, 2014

Report

Report Number
1049092-2014-00234
Event Type
Injury
Date Received
June 23, 2014
Date of Event
May 29, 2014
Report Date
May 29, 2014
Manufacturer
CONVATEC, INC
Product Code
EXE
PMA / PMN Number
K855018
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
RI, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

BASED ON THE AVAILABLE INFO, THIS EVENT IS DEEMED TO BE A SERIOUS INJURY. SKIN CARE ROUTINE AND APPLICATION OF STOMAHESIVE POWDER AND ANTI FUNGAL POWDERS WERE REVIEWED. WITH END-USER'S SON. IT WAS SUGGESTED THAT HE CONTACT A HEALTH CARE PROVIDER (HCP) AND TO REQUEST AN ANTI-FUNGAL POWDER. LASTLY, HE WAS ADVISED TO NOTIFY CONVATEC AFTER SPEAKING WITH HIS SISTER IN REGARDS TO THE WAFER FIT. NO ADD'L PT/EVENT DETAILS HAVE BEEN PROVIDED TO DATE. A RETURN SAMPLE FOR EVAL IS NOT EXPECTED. SHOULD ADD'L INFO BECOME AVAILABLE, A FOLLOW UP REPORT WILL BE SUBMITTED. (B)(4). NOTE: THE ACTUAL DATE OF EVENT IS UNK, SO THE DATE USED WAS THE DATE CONVATEC BECAME AWARE . CONVATEC WILL CONTINUE TO TRACK AND MONITOR SUCH COMPLAINTS ACCORDING TO CONVATEC INC'S. COMPLAINT HANDLING AND CAPA PROCEDURES.

Description of Event or Problem · 1

IT IS REPORTED THAT END-USER DEVELOPED A RASH WITH REDNESS ON THE LEFT ABDOMINAL SKIN BENEATH THE WAFER APPROX TWO AND A HALF (2 1/2) MONTHS AGO. THE ISSUE STARTED AS A RASH AND NOW THERE ARE TWO (2) AREAS ON RAWNESS THAT ARE WEEPY SO THE WAFER DOES NOT ADHERE WELL. IT IS UNCERTAIN IF THERE IS STILL LEAKING BENEATH THE WAFER OF WHETHER THE WAFER FIT PROPERLY OR NOT. PLEASE NOTE THAT THIS INFO WAS PROVIDED BY SON OF END-USER WHO HAD LIMITED DETAILS, AS HE DOES NOT PROVIDED DIRECT CARE TO HIS MOTHER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
367345 SUR-FIT NATURA 2 PC DURAHESIVE CONVEX MOLDABLE PROTECTOR, OSTOMY EXE CONVATEC, INC 404594 UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention